Return to content in this issue

Efficacy of mepolizumab for the treatment of eosinophilic cystitis: a report of two cases

Trefond L^1,2, Guy L³, Darcha C⁴, Gallon A⁵, Thomas-Monier R⁵, Berdugo K⁶, Smets P¹, Olagne L¹, Stievenart J¹, Fayard D_¹, Cathebras P⁶, Aumaitre O^1,2, Boyer L⁵, Andre M^1,2, Kahn JE<sup>7

1</sup>Service de Médecine Interne, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France
²Université Clermont Auvergne, Inserm U1071, M2iSH, USC-INRA 1382, 63000 Clermont-Ferrand, France
³Service d’Urologie, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France
⁴Service d’Anatomopathologie, CHU Estaing, Clermont Ferrand, France
⁵Service de Radiologie, CHU Gabriel Montpied, 63000 Clermont-Ferrand, France
⁶Service de Médecine Interne, CHU de Saint-Étienne, France
⁷National Reference Center for Hypereosinophilic Syndromes, CEREO, France; Université Paris-Saclay, Assistance Publique - Hôpitaux de Paris, Department of Internal Medicine, Ambroise Paré Hospital, F-92100 Boulogne-Billancourt, France

J Investig Allergol Clin Immunol 2024; Vol. 34(3)
doi: 10.18176/jiaci.0954